RNA vaccine
Jump to navigation
Jump to search
Indications
- treatment of cutaneous melanoma, including late-stage melanoma[1]
Advantages
Procedure
- typically enclosed in lipid nanocapsules
- injected & taken up by host dendritic cells
- the dendritic cells produce mRNA-encoded peptides (immunogens) in conjunction with major histocompatibility complex I proteins to elicit T-cell response
More general terms
References
- ↑ 1.0 1.1 Sahin U et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature 2020 Sep; 585:107. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32728218 https://www.nature.com/articles/s41586-020-2537-9